Thromb Haemost 1982; 47(03): 226-229
DOI: 10.1055/s-0038-1657173
Original Article
Schattauer GmbH Stuttgart

Pharmacological Studies on the Antithrombotic Action of Hirudin in Experimental Animals

F Markwardt
The Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Erfurt, G. D. R.
,
J Hauptmann
The Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Erfurt, G. D. R.
,
G Nowak
The Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Erfurt, G. D. R.
,
Ch Kleßen
The Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Erfurt, G. D. R.
,
P Walsmann
The Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Erfurt, G. D. R.
› Author Affiliations
Further Information

Publication History

Received 19 January 1982

Accepted 19 March 1982

Publication Date:
13 July 2018 (online)

Preview

Summary

The pharmacodynamics and pharmacokinetics of hirudin were studied in dogs, rabbits and rats. Hirudin proved to be a well tolerated substance with low toxicity. After intravenous injection it was eliminated with a half time of 50 to 60 min. It was nearly completely excreted through the kidneys in biologically active form. The efficacy of hirudin in preventing venous thrombosis, vascular shunt occlusion and disseminated intravascular coagulation in rats was demonstrated.